DRI Capital

DRI is a pioneer and global leader in healthcare royalty monetization with a 32-year history of collaboration with leading biotech and pharmaceutical companies, hospitals, universities and inventors. Between 2006 and 2018, DRI Capital, through three managed funds, acquired over 60 separate royalty streams for an aggregate value of over $2 billion on some of the world’s best-selling pharmaceutical products.